Low-carb diets, particularly keto, have ruled the weight-loss scene for over a decade. However, a new report by The New Consumer and Coefficient Capital suggests that the rise of GLP-1 drugs like Ozempic might be causing a significant shift. Google Trends data shows that in June, searches for “Ozempic” surpassed those for “keto”, indicating a major change in consumer interests.
Ozempic, a brand name for the drug semaglutide, has quickly gained popularity for its weight-loss benefits. But does this mean keto is disappearing for good? Experts warn that both methods have their advantages and disadvantages, with accessibility being a key difference.
The study that shows the shift to Ozempic
The report underscores the growing impact of Ozempic and other GLP-1 drugs in the diet landscape. These medications mimic natural hormones in the body that regulate appetite, helping users reduce cravings and eat less. Many users report fewer food obsessions and find calorie-dense foods like sweets and fried snacks less appealing.
This appetite-regulating effect has made GLP-1 drugs a game changer for many Americans. Between 8 million and 20 million people are currently using these medications, with an additional 25 million to 50 million expected to start in the next few years.
As GLP-1 use rises, the appeal of traditional diets like keto seems to be declining. Surveys show a drop in keto’s popularity, with 4% of dieters following the regimen in 2023, compared to 7% in 2022.
Ozempic vs. keto: pros and cons
While GLP-1 drugs offer clear benefits, they come with significant challenges. High costs —often exceeding $1,000 per month— and limited insurance coverage make these medications inaccessible for many. Even when available, side effects like nausea and vomiting can be off-putting for some users.
On the other hand, keto remains an affordable approach to weight loss and health management. By cutting carbs and focusing on fats, keto has shown promise for controlling blood sugar levels and managing diabetes. It also requires no doctor visits or expensive prescriptions.
However, keto’s health risks can’t be ignored. Diets high in saturated fats and processed meats are linked to higher risks of heart disease and cancer. This has led to criticism from health experts, consistently ranking keto among the least healthy diets. The extreme restrictions can also make the keto diet very difficult to follow.
The final verdict: Ozempic or keto diet?
As GLP-1 drugs like Ozempic continue to gain popularity, they are undoubtedly reshaping the weight-loss industry. Their ability to curb cravings and deliver significant results has made them a revolutionary tool for many looking to manage their weight. However, their high costs and limited availability mean that keto and other low-carb diets aren’t going away just yet.
For now, the two approaches coexist, serving different segments of the population. While Ozempic appeals to those who can afford medical intervention, keto offers a more accessible alternative for those wanting to take control of their health through diet alone. The future may see further changes as new solutions emerge, but for now, the battle between keto and GLP-1 drugs continues.